Skip to main content
SABS logo

SABS · SAB Biotherapeutics, Inc.

$3.45 +0.01 (+0.29%) At close · Jul 28
Market Cap
$263.04M
Shares
76.46M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
77/100
Short interest 5.7% of shares — P76 Days to cover 9.4 — P89 Price vs VWAP -9.3% — P32 Short-volume trend +28.4% — P96 Short interest change +16.0% — P79 Worst FTD 1.63% of shares — P94

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-07-31 Scheduled
FINRA publishes Aug 11
2026-07-15 4,376,175 3,773,336 +602,839 9.42
2026-06-30 3,773,336 2,876,593 +896,743 2.70
2026-06-15 2,876,593 2,644,665 +231,928 3.38
2026-05-29 2,644,665 2,746,317 -101,652 6.67
2026-05-15 2,746,317 2,418,434 +327,883 1.76
2026-04-30 2,418,434 3,000,764 -582,330 6.10
2026-04-15 3,000,764 2,504,815 +495,949 6.95
2026-03-31 2,504,815 1,953,472 +551,343 2.98
2026-03-13 1,953,472 1,613,558 +339,914 2.13
2026-02-27 1,613,558 1,860,014 -246,456 5.73
2026-02-13 1,860,014 1,945,809 -85,795 5.77
2026-01-30 1,945,809 1,559,953 +385,856 3.98
2026-01-15 1,559,953 1,447,052 +112,901 3.67
2025-12-31 1,447,052 901,471 +545,581 4.87
2025-12-15 901,471 702,326 +199,145 3.03
2025-11-28 702,326 676,534 +25,792 3.10
2025-11-14 676,534 696,993 -20,459 3.62
2025-10-31 696,993 692,718 +4,275 2.32
2025-10-15 692,718 497,544 +195,174 1.32
2025-09-30 497,544 405,214 +92,330 1.14
2025-09-15 405,214 440,483 -35,269 3.73
2025-08-29 440,483 501,956 -61,473 6.78
2025-08-15 501,956 745,629 -243,673 3.84
2025-07-31 745,629 21,050 +724,579 1.00
Showing 1–24 of 24 settlements
Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 6 filings 6 filers Visit website Investor relations